292 related articles for article (PubMed ID: 21752610)
1. Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system.
Mohammadi G; Nokhodchi A; Barzegar-Jalali M; Lotfipour F; Adibkia K; Ehyaei N; Valizadeh H
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):39-44. PubMed ID: 21752610
[TBL] [Abstract][Full Text] [Related]
2. Development of azithromycin-PLGA nanoparticles: physicochemical characterization and antibacterial effect against Salmonella typhi.
Mohammadi G; Valizadeh H; Barzegar-Jalali M; Lotfipour F; Adibkia K; Milani M; Azhdarzadeh M; Kiafar F; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Oct; 80(1):34-9. PubMed ID: 20558048
[TBL] [Abstract][Full Text] [Related]
3. Study of Antimicrobial Effects of Clarithromycin Loaded PLGA Nanoparticles against Clinical Strains of Helicobacter pylori.
Lotfipour F; Valizadeh H; Milani M; Bahrami N; Ghotaslou R
Drug Res (Stuttg); 2016 Jan; 66(1):41-5. PubMed ID: 25919643
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial activity of clarithromycin loaded PLGA nanoparticles.
Valizadeh H; Mohammadi G; Ehyaei R; Milani M; Azhdarzadeh M; Zakeri-Milani P; Lotfipour F
Pharmazie; 2012 Jan; 67(1):63-8. PubMed ID: 22393833
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery.
Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G
J Drug Target; 2011 Jul; 19(6):409-17. PubMed ID: 20678034
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Cellular Cytotoxicity and Antibacterial Activity of 18-β-Glycyrrhetinic Acid by Albumin-conjugated PLGA Nanoparticles.
Darvishi B; Manoochehri S; Esfandyari-Manesh M; Samadi N; Amini M; Atyabi F; Dinarvand R
Drug Res (Stuttg); 2015 Dec; 65(12):617-23. PubMed ID: 25607747
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
Dillen K; Vandervoort J; Van den Mooter G; Ludwig A
Int J Pharm; 2006 May; 314(1):72-82. PubMed ID: 16600538
[TBL] [Abstract][Full Text] [Related]
8. Preparation and physicochemical characterization of naproxen-PLGA nanoparticles.
Javadzadeh Y; Ahadi F; Davaran S; Mohammadi G; Sabzevari A; Adibkia K
Colloids Surf B Biointerfaces; 2010 Dec; 81(2):498-502. PubMed ID: 20719477
[TBL] [Abstract][Full Text] [Related]
9. Development of a new delivery system consisting in 'drug-in cyclodextrin-in PLGA nanoparticles'.
Mura P; Maestrelli F; Cecchi M; Bragagni M; Almeida A
J Microencapsul; 2010; 27(6):479-86. PubMed ID: 20113170
[TBL] [Abstract][Full Text] [Related]
10. Nafcillin-loaded PLGA nanoparticles for treatment of osteomyelitis.
Pillai RR; Somayaji SN; Rabinovich M; Hudson MC; Gonsalves KE
Biomed Mater; 2008 Sep; 3(3):034114. PubMed ID: 18708713
[TBL] [Abstract][Full Text] [Related]
11. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
13. Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles.
Esmaeili F; Hosseini-Nasr M; Rad-Malekshahi M; Samadi N; Atyabi F; Dinarvand R
Nanomedicine; 2007 Jun; 3(2):161-7. PubMed ID: 17468055
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
15. The characteristics and improved intestinal permeability of vancomycin PLGA-nanoparticles as colloidal drug delivery system.
Zakeri-Milani P; Loveymi BD; Jelvehgari M; Valizadeh H
Colloids Surf B Biointerfaces; 2013 Mar; 103():174-81. PubMed ID: 23201735
[TBL] [Abstract][Full Text] [Related]
16. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
Niu X; Zou W; Liu C; Zhang N; Fu C
Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
[TBL] [Abstract][Full Text] [Related]
17. Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release.
Saxena V; Sadoqi M; Shao J
Int J Pharm; 2004 Jul; 278(2):293-301. PubMed ID: 15196634
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of antibacterial activity of caffeic acid phenethyl ester and PLGA nanoparticle formulation by different methods.
Arasoglu T; Derman S; Mansuroglu B
Nanotechnology; 2016 Jan; 27(2):025103. PubMed ID: 26629915
[TBL] [Abstract][Full Text] [Related]
19. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies.
Joshi SA; Chavhan SS; Sawant KK
Eur J Pharm Biopharm; 2010 Oct; 76(2):189-99. PubMed ID: 20637869
[TBL] [Abstract][Full Text] [Related]
20. Preparation and antibacterial activity of compound chitosan-compound Yizhihao-nanoparticles.
Ou S; Zhang YD
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 May; 33(5):369-74. PubMed ID: 18544838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
